Clinical trial NCT01728155 - References

LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES — European Low and Intermediate Risk Neuroblastoma Protocol

Citation(s)

•   Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, Couturier J, Darnfors C, Delattre O, Freeman-Edward J, Gambini C, Gross N, Hattinger CM, Luegmayr A, Lunec J, Martinsson T, Mazzocco K, Navarro S, Noguera R, O'Neill S, Potschger U, Rumpler S, Speleman F, Tonini GP, Valent A, Van Roy N, Amann G, De Bernardi B, Kogner P, Ladenstein R, Michon J, Pearson AD, Ambros PF
  Quality assessment of genetic markers used for therapy stratification. J Clin Oncol. 2003 Jun 1;21(11):2077-84. doi: 10.1200/JCO.2003.03.025.
•   Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM
  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer. 2009 May 5;100(9):1471-82. doi: 10.1038/sj.bjc.6605014.
•   Ambros PF, Ambros IM, Kerbl R, Luegmayr A, Rumpler S, Ladenstein R, Amann G, Kovar H, Horcher E, De Bernardi B, Michon J, Gadner H
  Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol. 2001 Jan;36(1):1-4. doi: 10.1002/1096-911X(20010101)36:13.0.CO;2-L.
•   Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group
  Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005 Nov 24;353(21):2243-53. doi: 10.1056/NEJMoa052399.
•   Avni FE, Massez A, Cassart M
  Tumours of the fetal body: a review. Pediatr Radiol. 2009 Nov;39(11):1147-57. doi: 10.1007/s00247-009-1160-6. Epub 2009 Feb 24.
•   Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL; International Neuroblastoma Risk Group
  Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database. J Clin Oncol. 2009 Jan 20;27(3):365-70. doi: 10.1200/JCO.2008.17.9184. Epub 2008 Dec 1.
•   Barrette S, Bernstein ML, Leclerc JM, Champagne MA, Samson Y, Brossard J, Woods WG
  Treatment complications in children diagnosed with neuroblastoma during a screening program. J Clin Oncol. 2006 Apr 1;24(10):1542-5. doi: 10.1200/JCO.2005.04.4602.
•   Boglino C, Martins AG, Ciprandi G, Sousinha M, Inserra A
  Spinal cord vascular injuries following surgery of advanced thoracic neuroblastoma: an unusual catastrophic complication. Med Pediatr Oncol. 1999 May;32(5):349-52. doi: 10.1002/(sici)1096-911x(199905)32:53.0.co;2-p.
•   Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD; U
  K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol. 2001 Jan;36(1):14-9. doi: 10.1002/1096-911X(20010101)36:13.0.CO;2-G.
•   Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Lampert F, Boecker W, Dockhorn-Dworniczak B
  Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med Pediatr Oncol. 2001 Jan;36(1):11-3. doi: 10.1002/1096-911X(20010101)36:13.0.CO;2-M.
•   Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W, Dockhorn-Dworniczak B
  Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer. 1998 Jun;77(12):2223-9. doi: 10.1038/bjc.1998.370.
•   Brisse HJ, Aubert B
  [CT exposure from pediatric MDCT: results from the 2007-2008 SFIPP/ISRN survey]. J Radiol. 2009 Feb;90(2):207-15. doi: 10.1016/s0221-0363(09)72471-0. French.
•   Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS
  Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):93-101. doi: 10.1097/00043426-199703000-00001.
•   Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al
  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993 Aug;11(8):1466-77. doi: 10.1200/JCO.1993.11.8.1466.
•   Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, et al
  International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988 Dec;6(12):1874-81. doi: 10.1200/JCO.1988.6.12.1874.
•   Brodeur GM
  Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003 Mar;3(3):203-16. doi: 10.1038/nrc1014.
•   Brody AS, Frush DP, Huda W, Brent RL; American Academy of Pediatrics Section on Radiology
  Radiation risk to children from computed tomography. Pediatrics. 2007 Sep;120(3):677-82. doi: 10.1542/peds.2007-1910.
•   Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, Ladenstein R, Brichard B, Bermudez JD, Couturier J, de Bernardi B, Pearson AJ, Michon J
  Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol. 2009 Mar 1;27(7):1014-9. doi: 10.1200/JCO.2007.14.5839. Epub 2009 Jan 26.
•   Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R
  Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med. 1996 Jan 25;334(4):225-30. doi: 10.1056/NEJM199601253340404.
•   Castel V, Badal MD, Bezanilla JL, Llombart A, Ruiz-Jimenez JI, Sanchez de Toledo J, Melero C, Mulet J
  Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol. 1995 Jan;24(1):29-35. doi: 10.1002/mpo.2950240107.
•   Castleberry RP, Kun LE, Shuster JJ, Altshuler G, Smith IE, Nitschke R, Wharam M, McWilliams N, Joshi V, Hayes FA
  Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol. 1991 May;9(5):789-95. doi: 10.1200/JCO.1991.9.5.789.
•   Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, Horcher E, Neuenschwander S, Toma P, Rizzo A, Michon J, Holmes K
  Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005 Nov 20;23(33):8483-9. doi: 10.1200/JCO.2005.02.4661.
•   Chen CP, Chen SH, Chuang CY, Lee HC, Hwu YM, Chang PY, Chen ML, Chen BF
  Clinical and perinatal sonographic features of congenital adrenal cystic neuroblastoma: a case report with review of the literature. Ultrasound Obstet Gynecol. 1997 Jul;10(1):68-73. doi: 10.1046/j.1469-0705.1997.10010068.x.
•   Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force
  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.
•   Combaret V, Audoynaud C, Iacono I, Favrot MC, Schell M, Bergeron C, Puisieux A
  Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res. 2002 Jul 1;62(13):3646-8.
•   Crofton PM, Squires N, Davidson DF, Henderson P, Taheri S
  Reliability of urine collection pads for routine and metabolic biochemistry in infants and young children. Eur J Pediatr. 2008 Nov;167(11):1313-9. doi: 10.1007/s00431-008-0733-y. Epub 2008 May 21.
•   Daneman A, Baunin C, Lobo E, Pracros JP, Avni F, Toi A, Metreweli C, Ho SS, Moore L
  Disappearing suprarenal masses in fetuses and infants. Pediatr Radiol. 1997 Aug;27(8):675-81. doi: 10.1007/s002470050210.
•   De Bernardi B, Gerrard M, Boni L, Rubie H, Canete A, Di Cataldo A, Castel V, Forjaz de Lacerda A, Ladenstein R, Ruud E, Brichard B, Couturier J, Ellershaw C, Munzer C, Bruzzi P, Michon J, Pearson AD
  Excellent outcome with reduced treatment for infants with disseminated neuroblastoma without MYCN gene amplification. J Clin Oncol. 2009 Mar 1;27(7):1034-40. doi: 10.1200/JCO.2008.17.5877. Epub 2009 Jan 26.
•   De Bernardi B, Mosseri V, Rubie H, Castel V, Foot A, Ladenstein R, Laureys G, Beck-Popovic M, de Lacerda AF, Pearson AD, De Kraker J, Ambros PF, de Rycke Y, Conte M, Bruzzi P, Michon J; SIOP Europe Neuroblastoma Group
  Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer. 2008 Oct 7;99(7):1027-33. doi: 10.1038/sj.bjc.6604640. Epub 2008 Sep 2.
•   Deeg KH, Bettendorf U, Hofmann V
  Differential diagnosis of neonatal adrenal haemorrhage and congenital neuroblastoma by colour coded Doppler sonography and power Doppler sonography. Eur J Pediatr. 1998 Apr;157(4):294-7. doi: 10.1007/s004310050814.
•   Donoghue V, Ryan S, Twomey E
  Perinatal tumours: the contribution of radiology to management. Pediatr Radiol. 2008 Jun;38 Suppl 3:S477-83. doi: 10.1007/s00247-008-0841-x. No abstract available.
•   Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J
  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026.
•   Garaventa A, Boni L, Lo Piccolo MS, Tonini GP, Gambini C, Mancini A, Tonegatti L, Carli M, di Montezemolo LC, Di Cataldo A, Casale F, Mazzocco K, Cecchetto G, Rizzo A, Bernardi B; Italian Cooperative Group for Neuroblastoma
  Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. Ann Oncol. 2002 Jun;13(6):956-64. doi: 10.1093/annonc/mdf165.
•   Garaventa A, De Bernardi B, Pianca C, Donfrancesco A, Cordero di Montezemolo L, Di Tullio MT, Bagnulo S, Mancini A, Carli M, Pession A, Arrighini A, Di Cataldo A, Tamaro P, Iasonni V, Taccone A, Rogers D, Boni L; Italian Cooperative Group dor Neuroblastoma
  Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma. J Clin Oncol. 1993 Sep;11(9):1770-9. doi: 10.1200/JCO.1993.11.9.1770.
•   Gelfand MJ
  Meta-iodobenzylguanidine in children. Semin Nucl Med. 1993 Jul;23(3):231-42. doi: 10.1016/s0001-2998(05)80104-7.
•   Goo HW, Choi SH, Ghim T, Moon HN, Seo JJ
  Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol. 2005 Aug;35(8):766-73. doi: 10.1007/s00247-005-1459-x. Epub 2005 Apr 28.
•   Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J
  Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. J Nucl Med. 1990 Feb;31(2):129-34.
•   Goske MJ, Applegate KE, Boylan J, Butler PF, Callahan MJ, Coley BD, Farley S, Frush DP, Hernanz-Schulman M, Jaramillo D, Johnson ND, Kaste SC, Morrison G, Strauss KJ, Tuggle N
  The Image Gently campaign: working together to change practice. AJR Am J Roentgenol. 2008 Feb;190(2):273-4. doi: 10.2214/AJR.07.3526. No abstract available.
•   Gotoh T, Hosoi H, Iehara T, Kuwahara Y, Osone S, Tsuchiya K, Ohira M, Nakagawara A, Kuroda H, Sugimoto T
  Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol. 2005 Aug 1;23(22):5205-10. doi: 10.1200/JCO.2005.02.014.
•   Granata C, Fagnani AM, Gambini C, Boglino C, Bagnulo S, Cecchetto G, Federici S, Inserra A, Michelazzi A, Riccipetitoni G, Rizzo A, Tamaro P, Jasonni V, De Bernardi B
  Features and outcome of neuroblastoma detected before birth. J Pediatr Surg. 2000 Jan;35(1):88-91. doi: 10.1016/s0022-3468(00)80020-2.
•   Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F
  Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol. 2008 Mar 20;26(9):1504-10. doi: 10.1200/JCO.2007.12.3349.
•   Hoefnagel CA, De Kraker J, Valdes Olmos RA, Voute PA
  [131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):61-4.
•   Jacobs A, Delree M, Desprechins B, Otten J, Ferster A, Jonckheer MH, Mertens J, Ham HR, Piepsz A
  Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol. 1990;20(3):157-9. doi: 10.1007/BF02012960.
•   Janoueix-Lerosey I, Hupe P, Maciorowski Z, La Rosa P, Schleiermacher G, Pierron G, Liva S, Barillot E, Delattre O
  Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma. Cell Cycle. 2005 Dec;4(12):1842-6. doi: 10.4161/cc.4.12.2257. Epub 2005 Dec 14.
•   Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, Valteau-Couanet D, Thomas C, Combaret V, Rousseau R, Eggert A, Michon J, Speleman F, Delattre O
  Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol. 2009 Mar 1;27(7):1026-33. doi: 10.1200/JCO.2008.16.0630. Epub 2009 Jan 26.
•   Kellie SJ, Clague AE, McGeary HM, Smith PJ
  The value of catecholamine metabolite determination on untimed urine collections in the diagnosis of neural crest tumours in children. Aust Paediatr J. 1986 Nov;22(4):313-5. doi: 10.1111/j.1440-1754.1986.tb02156.x.
•   Kerbl R, Urban CE, Ambros IM, Dornbusch HJ, Schwinger W, Lackner H, Ladenstein R, Strenger V, Gadner H, Ambros PF
  Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors. J Clin Oncol. 2003 Nov 15;21(22):4228-34. doi: 10.1200/JCO.2003.10.168.
•   Kerbl R, Urban CE, Lackner H, Hofler G, Ambros IM, Ratschek M, Ambros PF
  Connatal localized neuroblastoma. The case to delay treatment. Cancer. 1996 Apr 1;77(7):1395-401. doi: 10.1002/(SICI)1097-0142(19960401)77:73.0.CO;2-W.
•   Khafagi FA, Shapiro B, Fischer M, Sisson JC, Hutchinson R, Beierwaltes WH
  Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med. 1991;18(3):191-8. doi: 10.1007/BF02262730.
•   Khafagi FA, Shapiro B, Gross MD
  The adrenal gland. In: Maisey MN, Britton KE, Gilday DL, eds. Clinical Nuclear Medicine. 2nd ed: London Chapman & Hall 1989:271-91.
•   Ladenstein R, Ambros IM, Potschger U, Amann G, Urban C, Fink FM, Schmitt K, Jones R, Slociak M, Schilling F, Ritter J, Berthold F, Gadner H, Ambros PF
  Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol. 2001 Jan;36(1):83-92. doi: 10.1002/1096-911X(20010101)36:13.0.CO;2-9.
•   Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS; United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group
  Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol. 2001 Jun 15;19(12):3080-90. doi: 10.1200/JCO.2001.19.12.3080.
•   Lee SY, Chuang JH, Huang CB, Hsiao CC, Wan YL, Ng SH, Lee TY, Ko SF
  Congenital bilateral cystic neuroblastoma with liver metastases and massive intracystic haemorrhage. Br J Radiol. 1998 Nov;71(851):1205-7. doi: 10.1259/bjr.71.851.10434918.
•   Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel CA, Jamadar DA, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin BL, Sisson JC, Thein A, Troncone L
  Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med. 1997 Sep;38(9):1352-7.
•   Lonergan GJ, Schwab CM, Suarez ES, Carlson CL
  Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002 Jul-Aug;22(4):911-34. doi: 10.1148/radiographics.22.4.g02jl15911.
•   Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM
  Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991 Apr;9(4):581-91. doi: 10.1200/JCO.1991.9.4.581.
•   Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C
  [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases]. Bull Cancer. 1988;75(1):97-106. French.
•   Lumbroso J, Hartmann O, Schlumberger M
  Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Societe Francaise d'Oncologie Pediatrique" and Nuclear Medicine Co-investigators. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):220-3.
•   Lumbroso JD, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Leclere JG, Couanet D, Bayle C, Caillaud JM, Lemerle J, et al
  Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res. 1988;271:689-705. No abstract available.
•   Luttikhuis ME, Powell JE, Rees SA, Genus T, Chughtai S, Ramani P, Mann JR, McConville CM
  Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer. 2001 Aug 17;85(4):531-7. doi: 10.1054/bjoc.2001.1960.
•   Mahony R, McParland P
  Approaches to the management of antenatally diagnosed congenital tumours. Pediatr Radiol. 2009 Nov;39(11):1173-8. doi: 10.1007/s00247-009-1163-3. Epub 2009 Mar 11.
•   Mairs RJ
  Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents. Eur J Cancer. 1999 Aug;35(8):1171-3. doi: 10.1016/s0959-8049(99)00114-8. No abstract available.
•   Maris JM, Matthay KK
  Molecular biology of neuroblastoma. J Clin Oncol. 1999 Jul;17(7):2264-79. doi: 10.1200/JCO.1999.17.7.2264.
•   Maris JM
  The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr. 2005 Feb;17(1):7-13. doi: 10.1097/01.mop.0000150631.60571.89.
•   Masiakos PT, Gerstle JT, Cheang T, Viero S, Kim PC, Wales P
  Is surgery necessary for incidentally discovered adrenal masses in children? J Pediatr Surg. 2004 May;39(5):754-8. doi: 10.1016/j.jpedsurg.2004.01.039.
•   Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP
  Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999 Oct 14;341(16):1165-73. doi: 10.1056/NEJM199910143411601.
•   Mendichovszky IA, Marks SD, Simcock CM, Olsen OE
  Gadolinium and nephrogenic systemic fibrosis: time to tighten practice. Pediatr Radiol. 2008 May;38(5):489-96; quiz 602-3. doi: 10.1007/s00247-007-0633-8. Epub 2007 Oct 18.
•   Modak S, Kushner BH, LaQuaglia MP, Kramer K, Cheung NK
  Management and outcome of stage 3 neuroblastoma. Eur J Cancer. 2009 Jan;45(1):90-8. doi: 10.1016/j.ejca.2008.09.016. Epub 2008 Nov 6.
•   Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD; INRG Task Force
  The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009 Jan 10;27(2):298-303. doi: 10.1200/JCO.2008.16.6876. Epub 2008 Dec 1.
•   Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM
  Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression. Genes Chromosomes Cancer. 2007 Oct;46(10):936-49. doi: 10.1002/gcc.20477.
•   Moyes J, McCready VR, Fullbrook AC
  Neuroblastoma MIBG in its diagnosis and management: Springer-Verlag Berlin and Heidelberg GmbH & Co. K 1989.
•   Nadler EP, Barksdale EM
  Adrenal masses in the newborn. Semin Pediatr Surg. 2000 Aug;9(3):156-64. doi: 10.1053/spsu.2000.7560.
•   Nishi M, Miyake H, Takeda T, Yonemori H, Hanai J, Kikuchi Y, Takasugi N
  A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma. Jpn J Clin Oncol. 1994 Oct;24(5):247-51.
•   Noguchi S, Masumoto K, Taguchi T, Takahashi Y, Tsuneyoshi M, Suita S
  Adrenal cytomegaly: two cases detected by prenatal diagnosis. Asian J Surg. 2003 Oct;26(4):234-6. doi: 10.1016/s1015-9584(09)60312-2.
•   Nuchtern JG
  Perinatal neuroblastoma. Semin Pediatr Surg. 2006 Feb;15(1):10-6. doi: 10.1053/j.sempedsurg.2005.11.003.
•   Ou P, Schmit P, Layouss W, Sidi D, Bonnet D, Brunelle F
  CT angiography of the artery of Adamkiewicz with 64-section technology: first experience in children. AJNR Am J Neuroradiol. 2007 Feb;28(2):216-9.
•   Oue T, Inoue M, Yoneda A, Kubota A, Okuyama H, Kawahara H, Nishikawa M, Nakayama M, Kawa K
  Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study. J Pediatr Surg. 2005 Feb;40(2):359-63. doi: 10.1016/j.jpedsurg.2004.10.062.
•   Parisi MT, Greene MK, Dykes TM, Moraldo TV, Sandler ED, Hattner RS
  Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol. 1992 Oct;27(10):768-73. doi: 10.1097/00004424-199210000-00003.
•   Park JR, Villablanca JG, London WB, Gerbing RB, Haas-Kogan D, Adkins ES, Attiyeh EF, Maris JM, Seeger RC, Reynolds CP, Matthay KK; Children's Oncology Group
  Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2009 Jan;52(1):44-50. doi: 10.1002/pbc.21784.
•   Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL
  Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol. 1999 Jan-Feb;21(1):13-8. doi: 10.1097/00043426-199901000-00004.
•   Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG
  Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol. 1997 Jan;150(1):81-9.
•   Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Benard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG, Speleman F
  Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer. 2001 Mar 1;91(5):680-6. doi: 10.1002/1097-0215(200002)9999:99993.0.co;2-r.
•   Pussard E, Neveux M, Guigueno N
  Reference intervals for urinary catecholamines and metabolites from birth to adulthood. Clin Biochem. 2009 Apr;42(6):536-9. doi: 10.1016/j.clinbiochem.2008.10.022. Epub 2008 Nov 11.
•   Rubie H, Michon J, Plantaz D, Peyroulet MC, Coze C, Frappaz D, Chastagner P, Baranzelli MC, Mechinaud F, Boutard P, Lutz P, Perel Y, Leverger G, de Lumley L, Millot F, Stephan JL, Margueritte G, Hartmann O
  Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique (SFOP). Br J Cancer. 1998 Jun;77(12):2310-7. doi: 10.1038/bjc.1998.384.
•   Sauvat F, Sarnacki S, Brisse H, Medioni J, Rubie H, Aigrain Y, Gauthier F, Audry G, Helardot P, Landais P, Michon J, Hartmann O, Nihoul-Fekete C
  Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer. 2002 May 1;94(9):2474-80. doi: 10.1002/cncr.10502.
•   Schleiermacher G, Bourdeaut F, Combaret V, Picrron G, Raynal V, Aurias A, Ribeiro A, Janoueix-Lerosey I, Delattre O
  Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain. Oncogene. 2005 May 5;24(20):3377-84. doi: 10.1038/sj.onc.1208486.
•   Schleiermacher G, Delattre O, Peter M, Mosseri V, Delonlay P, Vielh P, Thomas G, Zucker JM, Magdelenat H, Michon J
  Clinical relevance of loss heterozygosity of the short arm of chromosome 1 in neuroblastoma: a single-institution study. Int J Cancer. 1996 Apr 22;69(2):73-8. doi: 10.1002/(SICI)1097-0215(19960422)69:23.0.CO;2-S.
•   Schleiermacher G, Michon J, Huon I, d'Enghien CD, Klijanienko J, Brisse H, Ribeiro A, Mosseri V, Rubie H, Munzer C, Thomas C, Valteau-Couanet D, Auvrignon A, Plantaz D, Delattre O, Couturier J; Societe Francaise des Cancers de l'Enfant (SFCE)
  Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer. 2007 Jul 16;97(2):238-46. doi: 10.1038/sj.bjc.6603820. Epub 2007 Jun 19.
•   Schwab M, Westermann F, Hero B, Berthold F
  Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 2003 Aug;4(8):472-80. doi: 10.1016/s1470-2045(03)01166-5.
•   Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D
  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985 Oct 31;313(18):1111-6. doi: 10.1056/NEJM198510313131802.
•   Semelka RC, Armao DM, Elias J Jr, Huda W
  Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging. 2007 May;25(5):900-9. doi: 10.1002/jmri.20895.
•   Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH
  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985 Jun;26(6):576-85.
•   Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP
  The International Neuroblastoma Pathology Classification (the Shimada system). Cancer. 1999 Jul 15;86(2):364-72.
•   Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B
  Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999 Jul 15;86(2):349-63.
•   Shulkin BL, Shapiro B
  Current concepts on the diagnostic use of MIBG in children. J Nucl Med. 1998 Apr;39(4):679-88.
•   Siegel MJ, Jaju A
  MR imaging of neuroblastic masses. Magn Reson Imaging Clin N Am. 2008 Aug;16(3):499-513, vi. doi: 10.1016/j.mric.2008.04.007.
•   Sisson JC, Shulkin BL
  Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med. 1999 Sep;43(3):217-23.
•   Snow AB, Khalyfa A, Serpero LD, Capdevila OS, Kim J, Buazza MO, Gozal D
  Catecholamine alterations in pediatric obstructive sleep apnea: effect of obesity. Pediatr Pulmonol. 2009 Jun;44(6):559-67. doi: 10.1002/ppul.21015.
•   Sofka CM, Semelka RC, Kelekis NL, Worawattanakul S, Chung CJ, Gold S, Fordham LA
  Magnetic resonance imaging of neuroblastoma using current techniques. Magn Reson Imaging. 1999 Feb;17(2):193-8. doi: 10.1016/s0730-725x(98)00102-7.
•   Stark DD, Moss AA, Brasch RC, deLorimier AA, Albin AR, London DA, Gooding CA
  Neuroblastoma: diagnostic imaging and staging. Radiology. 1983 Jul;148(1):101-5. doi: 10.1148/radiology.148.1.6856817.
•   Suita S, Tajiri T, Higashi M, Tanaka S, Kinoshita Y, Takahashi Y, Tatsuta K
  Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan. Eur J Pediatr Surg. 2007 Feb;17(1):23-8. doi: 10.1055/s-2006-924640.
•   Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG
  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205.
•   Tsuchida Y, Ikeda H, Iehara T, Toyoda Y, Kawa K, Fukuzawa M
  Neonatal neuroblastoma: incidence and clinical outcome. Med Pediatr Oncol. 2003 Jun;40(6):391-3. doi: 10.1002/mpo.10235. No abstract available.
•   Uhl M, Altehoefer C, Kontny U, Il'yasov K, Buchert M, Langer M
  MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol. 2002 Sep;12(9):2335-8. doi: 10.1007/s00330-002-1310-9. Epub 2002 Mar 19.
•   Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, Nicholson J, O'Meara A, Plantaz D, Stallings R, Brichard B, Van den Broecke C, De Bie S, De Paepe A, Laureys G, Speleman F
  Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma. J Clin Oncol. 2005 Apr 1;23(10):2280-99. doi: 10.1200/JCO.2005.06.104.
•   Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D
  Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol. 2001 Jan;36(1):5-10. doi: 10.1002/1096-911X(20010101)36:13.0.CO;2-E.
•   Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F
  Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer. 1998 Oct;23(2):141-52. doi: 10.1002/(sici)1098-2264(199810)23:23.0.co;2-2.
•   Wang CH, Chen SJ, Yang LY, Tang RB
  Neonatal adrenal hemorrhage presenting as a multiloculated cystic mass. J Chin Med Assoc. 2008 Sep;71(9):481-4. doi: 10.1016/S1726-4901(08)70153-9.
•   Wieland DM, Wu J, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH
  Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980 Apr;21(4):349-53.
•   Wilson LM, Draper GJ
  Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974 Aug 3;3(5926):301-7. doi: 10.1136/bmj.3.5926.301.
•   Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW
  Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986 Jul 15;58(2 Suppl):598-602. doi: 10.1002/1097-0142(19860715)58:2+3.0.co;2-c.

European Low and Intermediate Risk Neuroblastoma Protocol

Details for clinical trial NCT01728155